S02 E07: Pharma in China, untapped markets and drug development - a podcast by EMG-Health

In this episode, GOLD is joined by Isabel Afonso, General Manager, Novartis Oncology China, who shares insights on the pharmaceutical landscape of the country and the potential of partnerships with multinational corporations, followed by a conversation with Dr Farid Khan, CEO and Founder, PharmaKure, about the vital ongoing need for drug development and the scientific details behind biopharmaceuticals. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Pharma in… China https://www.emg-gold.com/post/pharma-in-china 

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech 

A heyday for mRNA https://www.emg-gold.com/post/a-heyday-for-mrna  

The vast galaxy of neurology https://www.emg-gold.com/post/the-vast-galaxy-of-neurology 

Further episodes of The GOLD Podcast: Weekly Pharma Insights

Further podcasts by EMG-Health

Website of EMG-Health